LivsMed (491000.KQ) stock: key figures, P/E, revenue and dividend

Health Care · South Korea · ISIN KR7491000006

Price
40,100.00 KRW
Market cap
989.74 bn KRW
P/E (2025)
–
P/S (2025)
19.33
Dividend yield
0.00 %
Net margin
-44.68 %
Return on equity (ROE)
-12.65 %
Return on assets (ROA)
-11.33 %

LivsMed financials

Fiscal year20242025
Revenue27.12 bn KRW51.19 bn KRW
Gross profit14.55 bn KRW29.53 bn KRW
Operating income-26.50 bn KRW-22.64 bn KRW
EBIT-16.97 bn KRW-22.05 bn KRW
Net income-25.58 bn KRW-22.87 bn KRW
Diluted EPS – continuing operations-1,036.59 KRW-926.74 KRW

Full history since 2024, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About LivsMed

Livsmed Inc. engages in the research, development, manufacture, exports, and import of electro-diagnostic and electro-therapeutic apparatuses medical devices in South Korea. The company offers ArtiSential, a multi-joint articulating surgical instrument that is used for laparoscopic surgeries, as well as training kits. It exports to the Unites States, Germany, etc. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.